- Rx Response kicked into highest alert level as Hurricane Isaac made landfall
- Facing pharmacy trends for the remainder of the year
- NACDS responds to report on integrity of pharmaceutical supply chain
- The essential value of HIEs in delivering patient-centered pharmacy care
- Cardinal Health’s Independence Medical unit helps pharmacy owners tap into growing home healthcare market
NEW YORK — One of the world's largest pharmaceutical companies has acquired the maker and distributor of Emergen-C products.
Pfizer on Monday announced its acquisition of Alacer, a privately held company best known for its vitamin C supplement products. Financial terms of the transaction were not disclosed, but Pfizer did note that the deal would complement its Consumer Healthcare division.
“We are very pleased that the Emergen-C family of products will become part of Pfizer’s portfolio. We expect that our global network and deep expertise in dietary supplements combined with our desire to provide consumers with high-quality products will make Emergen-C more accessible than it has ever been before,” Pfizer Consumer Healthcare president Paul Sturman said. “Emergen-C products add to and greatly complement our market-leading dietary supplement portfolio.”